Document:

exhibit1012

EXHIBIT 10.12      INCENTIVE UNIT AGREEMENT    This INCENTIVE UNIT AGREEMENT (this “Agreement”), dated effective as of the IPO  Closing Date (as defined below), is entered into by and between Cure Aggregator, LLC, a  Delaware limited liability company (“Aggregator”), Cure TopCo, LLC, a Delaware limited  liability company (“Cure TopCo”) and Bradford Kyle Armbrester (“Executive”).    WHEREAS, on July 12, 2018 (the “Date of Grant”), Aggregator issued to Executive  122,500 Class B Common Units of Aggregator (the “Incentive Units”), each of which  corresponded to a Class B Common Unit of Cure TopCo (the “Corresponding Units”), pursuant to  the terms of (1) that certain Incentive Unit Award and Contribution Agreement, dated as of July  12, 2018, between Aggregator, Cure TopCo and Executive (the “Incentive Unit Agreement”), (2)  the Third Amended and Restated Limited Liability Company Agreement of Aggregator, dated as  of February 12, 2020 (the “Third Amended and Restated Aggregator LLC Agreement”), and (3)  the Second Amended and Restated Limited Liability Company Agreement of Cure TopCo, dated  as of November 27, 2019 (the “Second Amended and Restated LLC Agreement”);    WHEREAS, pursuant to that certain Reorganization Agreement, dated as of February 10,  2021 (the “Reorganization Agreement”), by and among Cure TopCo, Signify Health, Inc., a  Delaware corporation (“Pubco”), and the other parties thereto, the parties thereto are engaging in  the Reorganization Transactions (as defined in the Reorganization Agreement) in connection with  the IPO;    WHEREAS, as part of the Reorganization Transactions, and pursuant to the Third  Amended and Restated Limited Liability Company Agreement of Cure TopCo adopted on or  around the IPO Closing Date (as defined in the Reorganization Agreement) (as amended from time  to time, the “Cure TopCo LLC Agreement”) and the Fourth Amended and Restated Limited  Liability Company Agreement of Aggregator adopted on or around the IPO Closing Date (as  amended from time to time, the “Aggregator LLC Agreement”), all of the units of membership  interest in Cure TopCo existing immediately prior to the Reorganization Transactions, including  the Corresponding Units, are being reclassified and converted into LLC Units (as defined in the  Cure TopCo LLC Agreement) of Cure TopCo, and all of the units of membership interest in  Aggregator existing immediately prior to the Reorganization Transactions, including the Incentive  Units, are being reclassified and converted into Units (as defined in the Aggregator LLC  Agreement) of Aggregator; and    WHEREAS, to the extent that the Incentive Units and Corresponding Units are unvested  and/or subject to forfeiture under the terms of the Incentive Unit Agreement, the Third Amended  and Restated Aggregator LLC Agreement and the Second Amended and Restated LLC Agreement,  as applicable, as of the IPO Closing Date, then such restrictions, as amended pursuant to this  Agreement, shall continue to apply to the Units of Aggregator and the LLC Units of Cure TopCo  issued in exchange for the Incentive Units and Corresponding Units, respectively, as reflected in  this Agreement.    NOW, THEREFORE, in consideration of the mutual promises, covenants, and conditions  contained in this Agreement, the Reorganization Agreement, the Cure TopCo LLC Agreement and  

 

        the Aggregator LLC Agreement, and for other good and valuable consideration, the receipt and  sufficiency of which is hereby acknowledged, the parties covenant and agree as follows:    1. Capitalized Terms. The following capitalized terms, as used in this Agreement,  have the meanings given to them in this Section 1. Other capitalized terms have the meanings  given to them elsewhere in this Agreement or, if not so defined, in the Aggregator LLC Agreement  or the Cure TopCo LLC Agreement, as applicable.    “Acceleration Event” means (i) a Change in Control or (ii) the NM Members or their  respective direct or indirect parent entities, as applicable, ceasing to beneficially own, directly or  indirectly, at least 25% of the outstanding Pubco Common Stock (as determined on a fully diluted  basis).    “Base Equity Value” means the aggregate investment of the Pre-Combination NM  Members or their respective direct or indirect parent entities, as applicable, in the equity securities  of Cure TopCo (including (x) any cash dividend, (y) distribution, (z) the proceeds of any partial  liquidation of Cure TopCo; but excluding (A) any fees or expense reimbursements under any  applicable management or professional services agreement and (B) any fees and expenses realized  in connection with any Change in Control).    “Board” means the Board of Directors of Pubco.    “Cash-on-Cash Return” means, without duplication, the cumulative aggregate gross cash  return realized, and/or the fair market value of marketable securities received by the Pre-  Combination NM Members or their respective direct or indirect parent entities, as applicable, in  respect of the Base Equity Value, including, for the avoidance of doubt, any such return or  securities received by the Pre-Combination NM Members or their direct or indirect parent entities,  as applicable, on a disposition of Pubco Common Stock or of equity securities of the Company  (whether such disposition is to Pubco or otherwise); provided that with respect to any disposition  of Pubco Common Stock by the Pre-Combination NM Members, the Compensation Committee  will make such determinations in good faith as are necessary to allocate the proceeds received on  such disposition on a proportionate basis between the Cure TopCo Pubco Common Stock and the  shares of Pubco Common Stock held by the Pre-Combination NM Members that are not Cure  TopCo Pubco Common Stock. Any portion of any transaction consideration to be received by  equityholders of Pubco that is subject to any contingency or future event including, without  limitation, transaction escrow arrangement, holdback, installment arrangements or earnouts shall  be included in Cash-on-Cash Return if, when and to the extent actually received by the Pre-  Combination NM Members or, without duplication, their respective direct or indirect parent  entities, as applicable. If the Pre-Combination NM Members or, without duplication, their  respective direct or indirect parent entities, as applicable, receive non-marketable securities or  other non-cash property pursuant to a distribution or as proceeds from their aggregate investment  in equity securities of Cure TopCo, Executive shall be treated no less favorably than any other  member of the Board of Directors of Cure TopCo or officer of Cure TopCo and its Affiliates who  holds Incentive LLC Units with respect to the inclusion or exclusion of non-marketable securities  or other non-cash property from Cash-on-Cash Return.  

 

          “Cause” shall have the meaning ascribed to such term in the Employment Agreement or,  if not so defined, “Cause” means (i) Executive’s indictment for, conviction of, or a plea of guilty  or nolo contendere to, a (A) felony or (B) any crime of moral turpitude; (ii) Executive’s  embezzlement, breach of fiduciary duty or fraud with regard to the Company Group or any of its  assets or businesses; (iii) Executive’s continued failure to perform the duties of Executive’s  position, in the reasonable judgment of the Board; (iv) Executive’s dishonesty, willful misconduct,  or illegal conduct relating to the affairs of any member of the Company Group or its affiliates or  any of its customers; (v) Executive’s breach of a material provision of this Agreement or any other  contractual obligation to any member of the Company Group or its affiliates; or (vi) other conduct  by Executive that may be harmful to the business, interests, or reputation of the Company Group,  including any material violation of a Company Group policy. With respect to clauses (iii), (iv),  (v), and (vi) above, Aggregator shall provide ten (10) days written notice to Executive of its intent  to terminate for Cause, and during such ten (10) day period Executive shall have a right to cure (if  curable). If not cured within such period (as determined in the reasonable judgment of the Board,  the termination of Executive’s service will be effective upon the date immediately following the  expiration of the ten (10) day notice period. Notwithstanding anything to the contrary contained  herein, Executive’s right to cure as set forth above shall not apply if there are habitual or repeated  breaches by Executive.    “Change in Control” means the occurrence of any one or more of the following events:    (i) any Person, other than (a) any employee plan established by Pubco or any  Subsidiary, (b) Pubco or any of its Affiliates (including, for the avoidance of doubt, New Mountain  Capital, LLC and its Affiliates), (c) an underwriter temporarily holding securities pursuant to an  offering of such securities, or (d) an entity owned, directly or indirectly, by stockholders of Pubco  in substantially the same proportions as their ownership of Pubco, is (or becomes, during any 12-  month period) the “beneficial owner” (as such term is defined in Rule 13d-3 under the Securities  Exchange Act of 1934), directly or indirectly, of securities of Pubco (not including in the securities  beneficially owned by such Person any securities acquired directly from Pubco or its Affiliates  other than in connection with the acquisition by Pubco or its Affiliates of a business) representing  50% or more of the total voting power of the stock of Pubco; provided that the provisions of this  subsection (i) are not intended to apply to or include as a Change in Control any transaction that  is specifically excepted from the definition of Change in Control under subsection (iii) below;    (ii) the consummation of a merger, amalgamation or consolidation of Pubco with  any other corporation or other entity, or the issuance of voting securities in connection with such  a transaction pursuant to applicable stock exchange requirements; provided that immediately  following such transaction the voting securities of Pubco outstanding immediately prior thereto do  not continue to represent (either by remaining outstanding or by being converted into voting  securities of the surviving entity of such merger or consolidation or parent entity thereof) 50% or  more of the total voting power of Pubco’s stock (or, if Pubco is not the surviving entity of such  transaction, 50% or more of the total voting power of the stock of such surviving entity or parent  entity thereof); and provided, further, that such a transaction effected to implement a  recapitalization of Pubco (or similar transaction) in which no Person is or becomes the “beneficial  

 

        owner” (as such term is defined in Rule 13d-3 under the Securities Exchange Act of 1934), directly  or indirectly, of securities of Pubco (not including in the securities beneficially owned by such  Person any securities acquired directly from Pubco or its Affiliates other than in connection with  the acquisition by Pubco or its Affiliates of a business) representing 50% or more of either the  then-outstanding shares of Class A Common Stock or the combined voting power of Pubco’s then-  outstanding voting securities shall not be considered a Change in Control; or    (iii) the sale or disposition by Pubco of Pubco’s assets in which any Person acquires  (or has acquired during the 12-month period ending on the date of the most recent acquisition by  such Person) assets from Pubco that have a total gross fair market value equal to more than 50%  of the total gross fair market value of all of the assets of Pubco immediately prior to such  acquisition or acquisitions.    Notwithstanding the foregoing, (A) no Change in Control shall be deemed to have occurred  if there is consummated any transaction or series of integrated transactions immediately following  which the record holders of the Class A Common Stock immediately prior to such transaction or  series of transactions continue to have substantially the same proportionate ownership in an entity  which owns substantially all of the assets of Pubco immediately prior to such transaction or series  of transactions, and (B) no Change in Control shall be deemed to have occurred upon the  acquisition of additional control of Pubco by any Person that, prior to such transaction, directly or  indirectly controls, is controlled by, or is under common control with, Pubco.    “Company Group” means, at any given time, Pubco, Cure TopCo, Aggregator and their  Affiliates.    “Compensation Committee” means the Compensation Committee of the Board.    “Corresponding Class B Share” means, with respect to an Incentive LLC Unit, the share  of Class B Common Stock that was issued to Executive pursuant to the Class B Securities Purchase  Agreement entered into between Pubco and Executive and that corresponds to the Corresponding  Incentive Unit (as defined below).    “Cure TopCo Pubco Common Stock” means the shares of Pubco Common Stock received  by the Pre-Combination NM Members in connection with the Reorganization Transactions.    “Employment Agreement” means the applicable employment, retention or other  employment letter agreement entered into between Executive and a member of the Company  Group (or any predecessor entity).    “Good Reason” shall have the meaning ascribed to such term in the Employment  Agreement.    “IPO Closing Date” has the meaning given to such term in the Reorganization Agreement.  

 

        “NM Members” shall mean (i) New Mountain Partners V, L.P. and its Affiliates in respect  of their investment in Remedy Acquisition, LP, (ii) New Mountain Partners V (AIV-C), L.P., and  (iii) New Mountain Partners V (AIV-C2), L.P., and their respective Affiliates, in each case, other  than Pubco and its direct or indirect subsidiaries.    “Person” means any individual, corporation, partnership, limited liability company, trust,  estate, joint venture, governmental authority or other entity.    “Pre-Combination NM Members” shall mean (i) New Mountain Partners V (AIV-C), L.P.,  and (ii) New Mountain Partners V (AIV-C2), L.P., and their respective Affiliates, in each case,  other than Pubco and its direct and indirect subsidiaries.    “Terminated” or “Terminates” means, with respect to Executive, a Termination of  Employment or Service, as applicable.    “Termination of Employment or Service” means a termination of employment or service  (for reasons other than a military or personal leave of absence granted by Cure TopCo) of  Executive from the Company Group. Notwithstanding the foregoing, if no rights of Executive are  reduced or adversely affected, the Compensation Committee may otherwise define Termination of  Employment or Service thereafter, provided that any such change to the definition of the term  “Termination of Employment or Service” does not subject the applicable Incentive LLC Units to  Section 409A of the Code.    2. 83(b) Elections. After the issuance of the Corresponding Incentive Units and the  Incentive LLC Units as contemplated by this Agreement, Aggregator shall execute and deliver to  the Internal Revenue Service (the “IRS”) an election under Section 83(b) of the Code with respect  to the Corresponding Incentive Units and Executive shall execute and deliver to the IRS an election  under Section 83(b) of the Code in the form attached hereto as Appendix A with respect to the  Incentive LLC Units (together the “83(b) Elections”). Executive understands that under Section  83(b) of the Code, regulations promulgated thereunder, and certain IRS administrative  announcements, in the absence of an effective election under Section 83(b) of the Code, the excess  of the fair market value of any Incentive LLC Units, on the date on which any forfeiture restrictions  applicable to such Incentive LLC Units lapse, over the price paid for such Incentive LLC Units,  could be reportable as ordinary income at that time. For this purpose, the term “forfeiture  restrictions” includes the restrictions on transferability and the vesting and reversion conditions  imposed under Sections 3 and 4 of this Agreement. Executive understands that (i) in making an  83(b) Election, Executive may be taxed at the time the Incentive LLC Units are received hereunder  to the extent the fair market value of the Incentive LLC Units exceeds the price for such Incentive  LLC Units and (ii) in order to be effective, the 83(b) Elections must be filed with the IRS within  thirty (30) days after February 12, 2021. Executive hereby acknowledges that: (x) the foregoing  description of the tax consequences of the 83(b) Elections is not intended to be complete and,  among other things, does not describe state, local or foreign income and other tax consequences;  (y) none of Cure TopCo, Aggregator, the NM Members, any of their respective Affiliates or any  of their respective partners, members, equityholders, directors, officers, employees, agents or  representatives (each, a “Related Person”) has provided or is providing Executive with tax advice  

 

        regarding the 83(b) Elections or any other matter, and Cure TopCo, Aggregator and the NM  Members and their respective Affiliates have urged Executive to consult Executive’s own tax  advisor with respect to income taxation consequences of receiving, holding and disposing of the  Incentive LLC Units; and (z) none of Cure TopCo, Aggregator, the NM Members or any other  Related Person has advised Executive to rely on any determination by it or its representatives as  to the fair market value specified in the 83(b) Elections and will have no liability to Executive if  the actual fair market value of the Incentive LLC Units on the date hereof exceeds the amount  specified in the respective 83(b) Elections.    3. Incentive Units. The Units of Aggregator issued to Executive in exchange for  Executive’s Incentive Units (the “Incentive LLC Units”) and the LLC Units of Cure TopCo issued  to Aggregator in exchange for the Corresponding Common Units (the “Corresponding Incentive  Units”) are subject to the vesting conditions set forth in this Section 3. A portion of the Incentive  LLC Units and Corresponding Incentive Units, as set forth on Appendix B, shall be subject to  time-based vesting conditions (the “Time-Based Units”) and a portion of the Incentive LLC Units  and Corresponding Incentive Units, as set forth on Appendix B, shall be subject to performance-  based vesting conditions (the “Performance-Based Units”). For purposes of this Agreement and  the Aggregator LLC Agreement, the Incentive LLC Units and Corresponding Incentive Units  which have become vested in accordance with this Section 3 shall be referred to herein as the  “Vested Units” and the remaining Incentive LLC Units and Corresponding Incentive Units shall  be referred to herein as the “Unvested Units.” The Incentive LLC Units are subject to the  restrictions set forth in this Agreement.    3.1. Time-Based Units. Executive’s Time-Based Units shall continue to time  vest in accordance with the vesting schedule set forth on Appendix B. Except as otherwise  provided in this Agreement, there shall be no proportionate or partial vesting in the periods prior  to each vesting date set forth on Appendix B and all vesting shall occur only on the applicable  vesting date set forth on Appendix B, provided that Executive has not been Terminated prior to  each applicable vesting date. Notwithstanding the foregoing, any Time-Based Units shall become  fully vested upon the occurrence of an Acceleration Event, so long as Executive has not been  Terminated prior to the date of such Acceleration Event.    3.2. Performance-Based Units. Executive’s Performance-Based Units shall vest  based on the level of aggregate Cash-on-Cash Returns achieved by the Pre-Combination NM  Members (and/or, without duplication, their direct and indirect parent entities) in accordance with  the vesting schedule set forth on Appendix B; provided that Executive has not been Terminated  prior to the date the applicable Cash-on-Cash Return is achieved. There shall be no proportionate  or partial vesting for levels of achievement of Cash-on-Cash Return between the performance  thresholds set forth above, and all vesting shall occur on a cliff basis only to the extent that an  applicable Cash-on-Cash Return threshold is achieved; provided that Executive has not been  Terminated prior to the date the applicable Cash-on-Cash Return is achieved. For the avoidance  of doubt, in the event that the applicable Cash-on-Cash Return is not achieved at any point in time,  then the Performance-Based Units shall remain outstanding and eligible to continue to  performance vest upon a later achievement of the applicable Cash-on-Cash Returns; provided that  Executive has not been Terminated prior to the date on which vesting occurs; and provided, further,  

 

        that any Performance-Based Units that remain unvested at such time as the NM Members or their  respective direct or indirect parent entities cease to control any Equity Securities of Pubco shall be  forfeited and cancelled.    3.3. Tail Period. Notwithstanding anything in this Section 3 to the contrary, if  Executive is Terminated by Cure TopCo without Cause or resigns with Good Reason, any  Unvested Units shall remain outstanding and eligible to vest for a period of twelve (12) months  thereafter (such period, the “Tail Period”) and shall vest, if at all, upon the occurrence during the  Tail Period of (i) in the case of the Time-Based Units, an Acceleration Event or (ii) in the case of  the Performance-Based Units, the achievement of the applicable Cash-on-Cash Return. For the  avoidance of doubt, the unvested portion of the Time-Based Units or Performance-Based Units  that do not vest during the Tail Period shall be cancelled and forfeited as of the expiration of the  Tail Period, without any further action on the part of any party hereto.    3.4. Call Rights. Except as otherwise provided in this Agreement, in the event  of Executive’s Termination for any reason, Aggregator may repurchase from Executive and/or, as  applicable, any of his or her Permitted Transferees the portion of the Incentive LLC Units that are  Vested Units based on the most recent valuation under Section 409A of the Code obtained by Cure  TopCo, subject to the sole discretion of the Board. For purposes of this Section 3.4, all  requirements of Executive shall apply equally in full force and effect with respect to any Permitted  Transferee.    3.4.1. Aggregator shall have a period of one hundred eighty (180) days (or  such longer period as may be necessary to avoid changing the accounting treatment for the  acquisition of the Incentive LLC Units being repurchased from an equity-based accounting  treatment to a liability based accounting treatment (as contemplated by FASB ASC Topic  718)); provided that such period shall not exceed three hundred sixty-five (365) days  following the date of Executive’s Termination, in which to give notice in writing to  Executive of Aggregator’s election to exercise its repurchase rights hereunder and thirty  (30) days after delivery of such notice to pay the repurchase price and consummate the  repurchase transaction. For the sake of clarity, Aggregator may elect to repurchase any of  the Incentive LLC Units of Executive and/or, as applicable, any of his or her Permitted  Transferees in one or more separate transactions. The repurchase price, if any, payable  pursuant to Aggregator’s exercise of its repurchase rights hereunder shall be paid (i) by  delivery to Executive of wire transfer or a certified bank check or checks in the appropriate  amount payable to the order of Executive; (ii) by the cancellation of any indebtedness owed  by Executive to Aggregator, Cure TopCo or any of their Affiliates; or (iii) by issuance of  an unsecured promissory note bearing interest (payable at maturity) at a simple rate per  annum equal to the prime rate in effect at such time, with such note to have a maturity date  of no greater than seven (7) years following its issuance and otherwise on customary terms  and conditions for promissory notes of such type, including acceleration in the event of an  Acceleration Event; or (iv) any combination of clauses (i), (ii) or (iii) of this Section 3.4.1,  as determined in the sole discretion of Aggregator. Aggregator may choose to have a  designee purchase any Incentive LLC Units elected by it to be purchased hereunder so long  as Aggregator shall bear any reasonable costs and expenses of Executive in connection  

 

        with the sale to such designee that Executive would not have otherwise incurred in  connection with a sale to Aggregator. All references to Aggregator in this Section 3.4 shall  refer to such designee as the context requires. Executive agrees to take all necessary and  reasonable actions as directed by Aggregator in connection with the consummation of a  repurchase pursuant to this Section 3.4, including executing the applicable repurchase  documentation. Without limiting the generality of the foregoing, Aggregator shall be  entitled to receive customary representations and warranties from Executive regarding the  Incentive LLC Units being repurchased including, but not limited to, the representation  that Executive has good and marketable title to the Incentive LLC Units to be repurchased  free and clear of all liens, claims and other encumbrances.    3.5. Termination of Employment. If Executive’s employment or service  relationship Terminates (other than in the case of a Termination for Cause), irrespective of whether  Executive receives, in connection with such Termination, any severance or other payment from  Cure TopCo or any of its Affiliates under any employment or service agreement or otherwise, the  Incentive LLC Units, other than such portion that are Vested Units, shall terminate and be of no  further force and effect as of and following the close of business on the date of such Termination,  unless otherwise provided for in Section 3.3. Notwithstanding anything in this Agreement to the  contrary, and in addition to the rights of Aggregator set forth in this Section 3.5 (or any other right  Aggregator may have), the Incentive LLC Units, including the portion that are Vested Units, shall  immediately be forfeited and cancelled, without any consideration being paid therefore and  without further action by Aggregator or any other Person, upon a Termination of Executive by  Cure TopCo or any of its Affiliates for Cause.    4. Restrictions on Unvested Units; Forfeiture.    4.1. Executive may not offer or Transfer or agree to offer or Transfer, grant any  call option with respect to, borrow against, or enter into any swap or derivative transaction with  respect to any Incentive LLC Unit or any interest therein, unless such action is taken in accordance  with Article VI of the Aggregator LLC Agreement. Any attempted or purported Transfer or other  agreement in violation of this Agreement will be void ab initio.    4.2. Notwithstanding anything to the contrary in the Aggregator LLC  Agreement, Executive shall not have the right to exercise (and agrees not to exercise or purport to  exercise) the “Member Exchange” under the Aggregator LLC Agreement with respect to any  Unvested Units.    4.3. If any Vested Units are purchased pursuant to the call right described in  Section 3.4, then each Corresponding Class B Share shall simultaneously be forfeited to Pubco for  no consideration in accordance with Article 4 of the Cure TopCo LLC Agreement. If any Unvested  Units or Vested Units are forfeited upon Executive’s Termination of Employment or Service under  Section 3, then each such Unvested Unit (and its Corresponding Class B Share) or Vested Unit  (and its Corresponding Class B Share), as applicable, shall be immediately and automatically  forfeited to Aggregator or Cure TopCo, as applicable (or, in the case of a Corresponding Class B  Share,  to  Pubco),  in  each  case  free  and  clear  of  any  liens,  encumbrances  or  restrictions,  

 

        concurrently with the Termination of Employment or Service, and shall no longer be deemed  outstanding, without the payment of consideration or notice from Aggregator, Cure TopCo or  Pubco and without the need for further action on the part of any Person.    4.4. Except as provided in this Agreement, from and after the IPO Closing Date,  Executive shall have all the rights of a member of Aggregator with respect to the Incentive LLC  Units and as a stockholder of Pubco with respect to the Corresponding Class B Shares, including  the right to vote the Corresponding Class B Share in respect of a Vested Unit; provided, that any  capital stock or securities of Aggregator or Pubco that Executive receives with respect to the  Incentive LLC Units or Corresponding Class B Shares through a stock dividend, stock split,  reverse stock split, recapitalization, or similar transaction will be subject to the same restrictions  applicable to the Incentive LLC Units or Corresponding Class B Shares with respect to which such  capital stock or other securities was distributed or received, as set forth in this Agreement.  Executive will be the record owner of each Incentive LLC Unit until or unless such Incentive LLC  Unit reverts to Aggregator as provided under this Agreement or is Transferred in accordance with  the terms of this Agreement and the Aggregator LLC Agreement, and as record owner will be  entitled to all rights granted to owners of the LLC Units of Aggregator, except as expressly  provided under this Agreement or the Aggregator LLC Agreement.    4.5. The Corresponding Incentive Units and Incentive LLC Units shall be  uncertificated unless otherwise determined by Cure TopCo, in the case of the Corresponding  Incentive Units, or Aggregator, in the case of the Incentive LLC Units.    4.6. If Executive is not already a party to the Aggregator LLC Agreement, then  Executive agrees that upon execution of this Agreement, Executive agrees to join and become a  party to the Aggregator LLC Agreement and be fully bound by, and subject to all of the covenants,  terms and conditions of the Aggregator LLC Agreement as though an original party thereto and  Aggregator agrees to accept Executive as a party to the Aggregator LLC Agreement and that this  Agreement shall serve as Executive’s joinder to the Aggregator LLC Agreement.    4.7. By virtue of the issuance of the Incentive LLC Units hereunder and  Executive’s execution of this Agreement, Executive shall be deemed to have granted a power of  attorney to the Board of Directors of Aggregator with respect to all Incentive LLC Units owned  by Executive and acquired by Executive hereunder, which power of attorney shall, for the  avoidance of doubt, include a grant by Executive of a perpetual and irrevocable power of attorney  to Aggregator, with full right, power and authority to take all actions necessary and/or desirable  on behalf of Executive to effectuate the provisions of this Section 4.    5. Compensation Committee Discretion. The Compensation Committee shall in good  faith make all determinations necessary or appropriate to determine whether the Incentive LLC  Units shall have become vested. The Compensation Committee’s determinations shall be final,  binding and conclusive upon all parties, absent manifest error or bad faith. The Compensation  Committee may, in its sole discretion, provide for accelerated vesting of any portion of the  Incentive LLC Units at any time and for any reason.  

 

        6. No Right to Continued Service. Executive agrees that no provision contained in this  Agreement shall entitle Executive to remain employed by the Company Group, affect the right of  the Company Group to Terminate Executive’s employment at any time, or confer on Executive  any right to employment for a fixed term.    7. Executive Representations. Executive shall be deemed to acknowledge and make  the following representations and warranties and as otherwise may be requested by Cure TopCo  or Aggregator for compliance with applicable laws, and any issuances of Incentive LLC Units by  Aggregator and any issuance of Corresponding Incentive Units by Cure TopCo hereunder shall be  made in reliance upon the express representations and warranties of Executive:    7.1. Executive is acquiring and will hold the Incentive LLC Units to be issued  hereunder for investment for Executive’s account only and not with a view to, or for resale in  connection with, any “distribution” thereof within the meaning of the Securities Act or other  applicable securities laws.    7.2. Executive will not Transfer the Incentive LLC Units in violation of this  Agreement, the Aggregator LLC Agreement, the Securities Act (or the rules and regulations  promulgated thereunder) or under any other applicable securities laws; provided that, the foregoing  shall in no way limit Executive’s ability to Transfer the Incentive LLC Units pursuant to the  provisions of the Aggregator LLC Agreement. Executive agrees that Executive will not Transfer  the Incentive LLC Units to be issued hereunder unless and until Executive has complied with all  requirements of this Agreement and the Aggregator LLC Agreement applicable to the disposition  of such Incentive LLC Units.    7.3. Executive has had the opportunity to ask questions and receive answers  from Cure TopCo and Aggregator concerning the terms and conditions of the issuance of the  Incentive LLC Units and to obtain any additional information which Cure TopCo or Aggregator  possesses or can acquire without unreasonable effort or expense that Executive has requested.    7.4. Executive is an experienced and sophisticated investor and has such  knowledge and experience in financial and business matters as are necessary to evaluate the merits  and risks of an investment in the Incentive LLC Units and the Corresponding Incentive Units.    7.5. Executive has only relied on the advice of, or has consulted with,  Executive’s own legal, financial and tax advisors, and the determination of Executive to acquire  Incentive LLC Units pursuant to this Agreement has been made by Executive independent of any  statements or opinions as to the advisability of such acquisition or as to the properties, business,  prospects or condition (financial or otherwise) of Cure TopCo, Aggregator or any of their  respective Subsidiaries which may have been made or given by any other Person (including all  Persons acquiring Incentive LLC Units on the date hereof) or by any agent or employee of such  Person and independent of the fact that any other Person has decided to become a holder of  Incentive LLC Units.  

 

        7.6. Executive hereby represents and warrants that Executive is an “accredited  investor” as defined in Rule 501(a)(6) of Regulation D of the Securities Act as the result of having  (i) individual income in excess of $200,000 in each of 2019 and 2020, or joint income with  Executive’s spouse in excess of $300,000 in each of 2019 and 2020, and (ii) a reasonable  expectation of having individual income in excess of $200,000 in 2021, or joint income with  Executive’s spouse in excess of $300,000 in 2021.    8. Specific Performance. Each of the parties agrees that any breach of the terms of  this Agreement will result in irreparable injury and damage to the other parties, for which there is  no adequate remedy at law. Each of the parties therefore agrees that in the event of a breach or  any threat of breach, the other parties shall be entitled to an immediate injunction and restraining  order to prevent such breach, threatened breach or continued breach, and/or compelling specific  performance of this Agreement, without having to prove the inadequacy of money damages as a  remedy or balancing the equities between the parties. Such remedies shall be in addition to any  other remedies (including monetary damages) to which the other parties may be entitled at law or  in equity. Each party hereby waives any requirement for the securing or posting of any bond in  connection with any such equitable remedy.    9. Amendments and Waivers. The Board shall have the right to amend this  Agreement with the consent of Executive; provided, however, that to the extent necessary under  any applicable law, regulation, or exchange requirement, no amendment shall be effective unless  approved by the members of Aggregator if required by applicable law, regulation, or exchange  requirement.    10. Governing Law; Venue; Service of Process; Waiver of Jury Trials.    10.1. This Agreement shall be governed by, and construed in accordance with,  the laws of the State of Delaware, without giving effect to any choice of law or conflict of law  rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause  the application of the laws of any jurisdiction other than the State of Delaware. Any dispute  relating hereto shall be heard in the state or federal courts of Delaware, and the parties agree to  jurisdiction and venue therein (it being understood and agreed that any order from any such court  may be enforced in any other jurisdiction). Each of the parties hereto hereby waives, to the fullest  extent permitted by law, any right to trial by jury of any claim, demand, action, or cause of action  arising under or related to this Agreement whether now existing or hereafter arising, and whether  in contract, tort, equity, or otherwise. The parties hereto each hereby agrees and consents that any  such claim, demand, action, or cause of action shall be decided by court trial without a jury and  that the parties hereto may file an original counterpart of a copy of this Agreement with any court  as written evidence of the consent of the parties hereto to the waiver of their right to trial by jury.    10.2. Executive (i) agrees that service of process in any such claim, demand,  action, proceeding or cause of action arising under this Agreement may be effected by mailing a  copy of such process by registered or certified mail (or any substantially similar form of mail),  postage prepaid, to such party, in the case of Executive, at Executive’s address shown in the books  and records of Aggregator or Cure TopCo, in the case of Aggregator, at Aggregator’s principal  

 

        offices, attention General Counsel, or in the case of Cure TopCo, at Cure TopCo’s principal  offices, attention General Counsel, and (ii) agrees that nothing in this Agreement shall affect the  right to effect service of process in any other manner permitted by the laws of the State of  Delaware.    11. Severability. Whenever possible, each provision of this Agreement shall be  interpreted in such manner as to be effective and valid under applicable law, but if any provision  of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable  law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any  other provision or any other jurisdiction, but this Agreement shall be reformed, construed and  enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been  contained herein.    12. Notice. Unless otherwise provided herein, all notices, requests, demands, claims  and other communications to be given or delivered under or by reason of the provisions of this  Agreement shall be in writing and shall be deemed to have been duly received (a) upon receipt by  hand delivery, (b) upon receipt after being mailed by certified or registered mail, postage prepaid,  (c) the next business day after being sent via a nationally recognized overnight courier, or (d) upon  confirmation of delivery if transmitted by electronic mail electronic mail in portable document  format (PDF format) with an electronic read receipt requested, to the email address indicated  (provided a copy thereof is also sent by one of the other methods described in this Section 12. Such  notices, demands and other communications shall be sent to the address, email address or facsimile  number indicated below:  (a) If to Aggregator or Cure TopCo:  Cure Aggregator, LLC  Cure TopCo, LLC  c/o New Mountain Capital, L.L.C.  787 Seventh Avenue  New York, NY 10019  Attention: Vignesh Aier and Kyle Peterson  E-mail: vaier@newmountaincapital.com  kpeterson@newmountaincapital.com    Cure TopCo, LLC  4055 Valley View Lane, Suite 400  Dallas, Texas 75244  Attention: Bradford Kyle Armbrester and Steven Senneff  Email: karmbrester@signifyhealth.com  ssenneff@signifyhealth.com    with a copy (with shall not constitute notice) to:  David Polk & Wardwell, LLP  

 

        450 Lexington Avenue  New York, NY 10017  Attention: Shane Tintle and Jeffrey P. Crandall  Email: shane.tintle@davispolk.com  jeffrey.crandall@davispolk.com    (b) If to Executive, at the most recent address or electronic mail address contained in  the Aggregator’s and Cure TopCo’s records.    13. Dispute Resolution. Any dispute or disagreement which may arise under, or as a  result of, or which may in any way relate to, the interpretation, or construction or of this Agreement  shall be determined by the Compensation Committee, in good faith, whose determination shall be  final, binding and conclusive for all purposes.    14. Successors and Assigns. This Agreement shall be binding on, inure to the benefit  of and be enforceable by Cure TopCo, Aggregator, Executive and their respective personal  representatives, heirs, successors and assigns (including all subsequent holders of one or more of  the Incentive LLC Units). Any Person acquiring or claiming an interest in an Incentive LLC Unit,  in any manner whatsoever, shall be subject to and bound by all terms, conditions and restrictions  of this Agreement without regard to whether such Person has executed a counterpart hereof or any  other document contemplated hereby.    15. Notice. All notices, consents, waivers and other communications required or  permitted by this Agreement shall be in writing and shall be deemed given to a party when  delivered or sent in accordance with Section 9.5 of the Aggregator LLC Agreement (to, in the case  of Executive, the address kept on file in Cure TopCo’s or Aggregator’s records).    16. Counterparts. This Agreement may be executed in one or more counterparts, each  of which shall be deemed to be an original but all of which together will constitute one and the  same instrument. A facsimile or portable document format (PDF) copy of a counterpart signature  page to this Agreement shall be deemed an original for all purposes.    17. Entire Agreement. This Agreement sets forth the entire agreement of the parties  hereto with respect to the subject matter contained herein and supersede all prior agreements,  promises, covenants, arrangements, communications, representations or warranties, whether oral  or written, by any officer, member, manager or representative of any party hereto in respect of  such subject matter. Without limiting the forgoing, this Agreement supersedes and replaces the  Incentive Unit Agreement (other than with respect to any restrictive covenants set forth therein)  which shall be of no further force and effect as of the IPO Closing Date.    18. Transfer of Personal Data. Executive authorizes, agrees and unambiguously  consents to the transmission by Cure TopCo or Aggregator (or any Affiliate of Cure TopCo or  Aggregator) of any personal data information related to the Incentive LLC Units awarded under  this Agreement for legitimate business purposes. This authorization and consent is freely given by  Executive.  

 

          19. Effectiveness. This Agreement shall be effective as of the IPO Closing Date  (contingent on the closing of the IPO). If the IPO Closing Date does not occur for any reason, then  (a) this Agreement shall be null and void, and (b) Executive shall continue to own the Incentive  Units subject to the Third Amended and Restated Aggregator LLC Agreement, the Second  Amended and Restated LLC Agreement and the Incentive Unit Agreement.    [Signature Page Follows]  

 

DocuSign Envelope ID: ADCEF105-6181-4F27-BA9C-BADEA80D05C8              SIGNATURE PAGE  TO  INCENTIVE UNIT AGREEMENT    IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the  date first above written.      Print Name:   Bradford Kyle Armbrester        CURE TOPCO, LLC    By:     Name:   Steven Senneff   Title: Chief Financial Officer       CURE AGGREGATOR, LLC          Accepted and agreed:  By:     Name: Kyle Peterson   Title:     VP/Treasurer       KA Family Investments LLC      Name:  Bradford Kyle Armbrester    Title:    Chief Executive Officer    3/8/2021  Date:      Accepted and agreed:      PA Family Enterprises LLC      Name:  Bradford Kyle Armbrester    Title:    Chief Executive Officer    3/8/2021  Date:    

 

DocuSign Envelope ID: ADCEF105-6181-4F27-BA9C-BADEA80D05C8              Appendix A    PROTECTIVE ELECTION TO INCLUDE AMOUNT IN GROSS INCOME  PURSUANT TO SECTION 83(b) OF THE INTERNAL REVENUE CODE    On February 12, 2021, the undersigned acquired 3,155,907 LLC Units (the “Incentive LLC  Units”) of Cure Aggregator, LLC, a Delaware limited liability company (“Aggregator”) with a  value of $24.00 per Incentive LLC Unit in exchange for LLC Units of Aggregator. The total  amount paid by the undersigned for the Incentive LLC Units was LLC Units of Aggregator with  an aggregate value of $7,574,328. The Incentive LLC Units are subject to a substantial risk of  forfeiture (described below) that may not be avoided by a transfer of the Incentive LLC Units to  another person and are also subject to certain restrictions on transfer.  The undersigned desires to make an election to have the receipt of the Incentive LLC Units  taxed under the provisions of Code §83(b) at the time the undersigned acquired the Incentive LLC  Units.  Therefore, pursuant to Code §83(b) and Treasury Regulation §1.83-2 promulgated  thereunder, the undersigned hereby makes an election, with respect to the Incentive LLC Units  (described below), to report as taxable income for calendar year 2021 the excess (if any) of the  Incentive LLC Units’ fair market value on February 12, 2021 over the purchase price thereof.  The following information is supplied in accordance with Treasury Regulation §1.83-2(e):  1. The name, address and social security number of the undersigned:  Name: Bradford Kyle Armbrester  Address:      SSN:       2. A description of the property with respect to which the election is being made: 3,155,907 LLC  Units of Aggregator.  3. The date on which the Incentive LLC Units were transferred: February 12, 2021.  The taxable  year for which such election is made: 2021.  4. The restrictions to which the property is subject: Under certain circumstances, the Incentive  LLC Units may be forfeited.  5. The fair market value on February 12, 2021 of the property with respect to which the election  is being made, determined without regard to any lapse restrictions: $7,574,328.  6. The amount paid or to be paid for such property: LLC Units of Aggregator with an aggregate  fair market value of $7,574,328.  * * * * *        A copy of this election has been furnished to Aggregator pursuant to Treasury Regulations §1.83-  2(d).  

 

DocuSign Envelope ID: ADCEF105-6181-4F27-BA9C-BADEA80D05C8                Dated: , 2021          Bradford Kyle Armbrestor  

 

DocuSign Envelope ID: ADCEF105-6181-4F27-BA9C-BADEA80D05C8              Appendix B    Number of Incentive LLC Units: 3,155,907  Number of Corresponding Incentive Units: 3,155,907    Number of Time-Based Units: 1,513,547  Number of Performance-Based Units: 1,642,360      Time-Based Unit Vesting Schedule: In equal 6.25% installments on each three month  anniversary of May 9, 2018, such that 100% of the Time-Based Units will be vested on May 9,  2022.    Performance-Based Unit Vesting Schedule:    Percentage Vesting Cash-on-Cash Return  0.00% Less than 2.00 times the Base Equity Value  46.00%  2.00 times the Base Equity Value  54.00% 3.00 times the Base Equity Value  

 

DocuSign Envelope ID: ADCEF105-6181-4F27-BA9C-BADEA80D05C8            Certificate Of Completion    Envelope Id: 5F1E82B0BD364B118B426CC3DD939348 Status: Completed  Subject: Please DocuSign: Converted IU Agreement_Armbrester former Class B.pdf  Source Envelope:  Document Pages: 18 Signatures: 3 Envelope Originator:  Certificate Pages: 1 Initials: 0 Barbara Waters  AutoNav: Enabled  EnvelopeId Stamping: Disabled  Time Zone: (UTC-06:00) Central Time (US & Canada)  4055 Valley View Ln # 700  Dallas, TX  75244-5074  bwaters@signifyhealth.com  IP Address: 75.115.162.90  Record Tracking    Status: Original  3/8/2021 4:53:05 PM  Holder: Barbara Waters  bwaters@signifyhealth.com  Location: DocuSign      Kyle Armbrester  karmbrester@signifyhealth.com  CEO  Security Level: Email, Account Authentication  (Optional) Signature Adoption: Pre-selected Style  Using IP Address: 68.161.208.252  Signed using mobile  Sent: 3/8/2021 5:00:19 PM  Viewed: 3/8/2021 5:01:01 PM  Signed: 3/8/2021 5:20:47 PM  Electronic Record and Signature Disclosure:  Not Offered via DocuSign                          Barbara Waters  bwaters@signifyhealth.com  Security Level: Email, Account Authentication  (Optional)  Electronic Record and Signature Disclosure:  Not Offered via DocuSign  Sent: 3/8/2021 5:00:19 PM  Resent: 3/8/2021 5:20:48 PM    Witness Events Signature Timestamp  Notary Events Signature Timestamp  Envelope Summary Events Status Timestamps  Envelope Sent  Certified Delivered  Signing Complete  Completed  Hashed/Encrypted  Security Checked  Security Checked  Security Checked  3/8/2021 5:00:19 PM  3/8/2021 5:01:01 PM  3/8/2021 5:20:47 PM  3/8/2021 5:20:47 PM  Payment Events Status Timestamps    Carbon Copy Events Status Timestamp  Certified Delivery Events Status Timestamp  Intermediary Delivery Events Status Timestamp  Agent Delivery Events Status Timestamp  Editor Delivery Events Status Timestamp  In Person Signer Events Signature Timestamp  Signer Events Signature Timestampexhibit1013

EXHIBIT 10.13  INCENTIVE UNIT AGREEMENT    This INCENTIVE UNIT AGREEMENT (this “Agreement”), dated effective as of the IPO  Closing Date (as defined below), is entered into by and between Cure Aggregator, LLC, a  Delaware limited liability company (“Aggregator”), Cure TopCo, LLC, a Delaware limited  liability company (“Cure TopCo”) and Steven Senneff (“Executive”).    WHEREAS, on February 14, 2020 (the “Date of Grant”), Aggregator issued to Executive  32,381 Class C Common Units of Aggregator (the “Incentive Units”), each of which corresponded  to a Class C Common Unit of Cure TopCo (the “Corresponding Units”), pursuant to the terms of  (1) that certain Incentive Unit Award Agreement, dated as of February 14, 2020, between  Aggregator, Cure TopCo and Executive (the “Incentive Unit Agreement”), (2) the Third Amended  and Restated Limited Liability Company Agreement of Aggregator, dated as of February 12, 2020  (the “Third Amended and Restated Aggregator LLC Agreement”), and (3) the Second Amended  and Restated Limited Liability Company Agreement of Cure TopCo, dated as of November 27,  2019 (the “Second Amended and Restated LLC Agreement”);    WHEREAS, pursuant to that certain Reorganization Agreement, dated as of February 10,  2021 (the “Reorganization Agreement”), by and among Cure TopCo, Signify Health, Inc., a  Delaware corporation (“Pubco”), and the other parties thereto, the parties thereto are engaging in  the Reorganization Transactions (as defined in the Reorganization Agreement) in connection with  the IPO;    WHEREAS, as part of the Reorganization Transactions, and pursuant to the Third  Amended and Restated Limited Liability Company Agreement of Cure TopCo adopted on or  around the IPO Closing Date (as defined in the Reorganization Agreement) (as amended from time  to time, the “Cure TopCo LLC Agreement”) and the Fourth Amended and Restated Limited  Liability Company Agreement of Aggregator adopted on or around the IPO Closing Date (as  amended from time to time, the “Aggregator LLC Agreement”), all of the units of membership  interest in Cure TopCo existing immediately prior to the Reorganization Transactions, including  the Corresponding Units, are being reclassified and converted into LLC Units (as defined in the  Cure TopCo LLC Agreement) of Cure TopCo, and all of the units of membership interest in  Aggregator existing immediately prior to the Reorganization Transactions, including the Incentive  Units, are being reclassified and converted into Units (as defined in the Aggregator LLC  Agreement) of Aggregator; and    WHEREAS, to the extent that the Incentive Units and Corresponding Units are unvested  and/or subject to forfeiture under the terms of the Incentive Unit Agreement, the Third Amended  and Restated Aggregator LLC Agreement and the Second Amended and Restated LLC Agreement,  as applicable, as of the IPO Closing Date, then such restrictions, as amended pursuant to this  Agreement, shall continue to apply to the Units of Aggregator and the LLC Units of Cure TopCo  issued in exchange for the Incentive Units and Corresponding Units, respectively, as reflected in  this Agreement.    NOW, THEREFORE, in consideration of the mutual promises, covenants, and conditions  contained in this Agreement, the Reorganization Agreement, the Cure TopCo LLC Agreement and  

 

the Aggregator LLC Agreement, and for other good and valuable consideration, the receipt and  sufficiency of which is hereby acknowledged, the parties covenant and agree as follows:    1. Capitalized Terms. The following capitalized terms, as used in this Agreement,  have the meanings given to them in this Section 1. Other capitalized terms have the meanings  given to them elsewhere in this Agreement or, if not so defined, in the Aggregator LLC Agreement  or the Cure TopCo LLC Agreement, as applicable.    “Acceleration Event” means (i) a Change in Control or (ii) the NM Members or their  respective direct or indirect parent entities, as applicable, ceasing to beneficially own, directly or  indirectly, at least 25% of the outstanding Pubco Common Stock (as determined on a fully diluted  basis).    “Base Equity Value” means the cumulative total of (i) the aggregate value of all equity  securities held by the NM Members and their respective direct or indirect parent entities, as  applicable, as of the closing of the transactions contemplated by the Combination Agreement (as  amended, restated, supplemented or otherwise modified from time to time), dated as of November  14, 2019, by and between Cure TopCo and Remedy Partners, LLC, a Delaware limited liability  company (formerly known as Remedy Partners, Inc.) (the “Combination Closing Date”) plus (ii)  any additional investment in equity securities of Cure TopCo by the NM Members and their  respective direct or indirect parent entities, as applicable, following the Combination Closing Date  (including (x) any cash dividend, (y) distribution, (z) the proceeds of any partial liquidation of  Cure TopCo; but excluding (A) any fees or expense reimbursements under any applicable  management or professional services agreement and (B) any fees and expenses realized in  connection with any Change in Control).    “Board” means the Board of Directors of Pubco.    “Cash-on-Cash Return” means, without duplication, the cumulative aggregate gross cash  return realized, and/or the fair market value of marketable securities received by the NM Members  or their respective direct or indirect parent entities, as applicable, in respect of the Base Equity  Value, including, for the avoidance of doubt, any such return or securities received by the NM  Members or their direct or indirect parent entities, as applicable, on a disposition of Pubco  Common Stock or of equity securities of the Company (whether such disposition is to Pubco or  otherwise); provided that with respect to any disposition of Pubco Common Stock by the NM  Members, the Compensation Committee will make such determinations in good faith as are  necessary to allocate the proceeds received on such disposition on a proportionate basis between  the Cure TopCo Pubco Common Stock and the shares of Pubco Common Stock held by the NM  Members that are not Cure TopCo Pubco Common Stock. Any portion of any transaction  consideration to be received by equityholders of Pubco that is subject to any contingency or future  event including, without limitation, transaction escrow arrangement, holdback, installment  arrangements or earnouts shall be included in Cash-on-Cash Return if, when and to the extent  actually received by the NM Members or, without duplication, their respective direct or indirect  parent entities, as applicable. If the NM Members or, without duplication, their respective direct  or indirect parent entities, as applicable, receive non-marketable securities or other non-cash  

 

3      property pursuant to a distribution or as proceeds from their aggregate investment in equity  securities of Cure TopCo, Executive shall be treated no less favorably than any other member of  the Board of Directors of Cure TopCo or officer of Cure TopCo and its Affiliates who holds  Incentive LLC Units with respect to the inclusion or exclusion of non-marketable securities or  other non-cash property from Cash-on-Cash Return.    “Cause” shall have the meaning ascribed to such term in the Employment Agreement or,  if not so defined, “Cause” means (i) Executive’s indictment for, conviction of, or a plea of guilty  or nolo contendere to, a (A) felony or (B) any crime of moral turpitude; (ii) Executive’s  embezzlement, breach of fiduciary duty or fraud with regard to the Company Group or any of its  assets or businesses; (iii) Executive’s continued failure to perform the duties of Executive’s  position, in the reasonable judgment of the Board; (iv) Executive’s dishonesty, willful misconduct,  or illegal conduct relating to the affairs of any member of the Company Group or its affiliates or  any of its customers; (v) Executive’s breach of a material provision of this Agreement or any other  contractual obligation to any member of the Company Group or its affiliates; or (vi) other conduct  by Executive that may be harmful to the business, interests, or reputation of the Company Group,  including any material violation of a Company Group policy. With respect to clauses (iii), (iv),  (v), and (vi) above, Aggregator shall provide ten (10) days written notice to Executive of its intent  to terminate for Cause, and during such ten (10) day period Executive shall have a right to cure (if  curable). If not cured within such period (as determined in the reasonable judgment of the Board,  the termination of Executive’s service will be effective upon the date immediately following the  expiration of the ten (10) day notice period. Notwithstanding anything to the contrary contained  herein, Executive’s right to cure as set forth above shall not apply if there are habitual or repeated  breaches by Executive.    “Change in Control” means the occurrence of any one or more of the following events:    (i) any Person, other than (a) any employee plan established by Pubco or any  Subsidiary, (b) Pubco or any of its Affiliates (including, for the avoidance of doubt, New Mountain  Capital, LLC and its Affiliates), (c) an underwriter temporarily holding securities pursuant to an  offering of such securities, or (d) an entity owned, directly or indirectly, by stockholders of Pubco  in substantially the same proportions as their ownership of Pubco, is (or becomes, during any 12-  month period) the “beneficial owner” (as such term is defined in Rule 13d-3 under the Securities  Exchange Act of 1934), directly or indirectly, of securities of Pubco (not including in the securities  beneficially owned by such Person any securities acquired directly from Pubco or its Affiliates  other than in connection with the acquisition by Pubco or its Affiliates of a business) representing  50% or more of the total voting power of the stock of Pubco; provided that the provisions of this  subsection (i) are not intended to apply to or include as a Change in Control any transaction that  is specifically excepted from the definition of Change in Control under subsection (iii) below;    (ii) the consummation of a merger, amalgamation or consolidation of Pubco with  any other corporation or other entity, or the issuance of voting securities in connection with such  a transaction pursuant to applicable stock exchange requirements; provided that immediately  following such transaction the voting securities of Pubco outstanding immediately prior thereto do  not continue to represent (either by remaining outstanding or by being converted into voting  

 

4      securities of the surviving entity of such merger or consolidation or parent entity thereof) 50% or  more of the total voting power of Pubco’s stock (or, if Pubco is not the surviving entity of such  transaction, 50% or more of the total voting power of the stock of such surviving entity or parent  entity thereof); and provided, further, that such a transaction effected to implement a  recapitalization of Pubco (or similar transaction) in which no Person is or becomes the “beneficial  owner” (as such term is defined in Rule 13d-3 under the Securities Exchange Act of 1934), directly  or indirectly, of securities of Pubco (not including in the securities beneficially owned by such  Person any securities acquired directly from Pubco or its Affiliates other than in connection with  the acquisition by Pubco or its Affiliates of a business) representing 50% or more of either the  then-outstanding shares of Class A Common Stock or the combined voting power of Pubco’s then-  outstanding voting securities shall not be considered a Change in Control; or    (iii) the sale or disposition by Pubco of Pubco’s assets in which any Person acquires  (or has acquired during the 12-month period ending on the date of the most recent acquisition by  such Person) assets from Pubco that have a total gross fair market value equal to more than 50%  of the total gross fair market value of all of the assets of Pubco immediately prior to such  acquisition or acquisitions.    Notwithstanding the foregoing, (A) no Change in Control shall be deemed to have occurred  if there is consummated any transaction or series of integrated transactions immediately following  which the record holders of the Class A Common Stock immediately prior to such transaction or  series of transactions continue to have substantially the same proportionate ownership in an entity  which owns substantially all of the assets of Pubco immediately prior to such transaction or series  of transactions, and (B) no Change in Control shall be deemed to have occurred upon the  acquisition of additional control of Pubco by any Person that, prior to such transaction, directly or  indirectly controls, is controlled by, or is under common control with, Pubco.    “Company Group” means, at any given time, Pubco, Cure TopCo, Aggregator and their  Affiliates.    “Compensation Committee” means the Compensation Committee of the Board.    “Corresponding Class B Share” means, with respect to an Incentive LLC Unit, the share  of Class B Common Stock that was issued to Executive pursuant to the Class B Securities Purchase  Agreement entered into between Pubco and Executive and that corresponds to the Corresponding  Incentive Unit (as defined below).    “Cure TopCo Pubco Common Stock” means the shares of Pubco Common Stock received  by the NM Members in connection with the Reorganization Transactions.    “Employment Agreement” means the applicable employment, retention or other  employment letter agreement entered into between Executive and a member of the Company  Group (or any predecessor entity).    “IPO Closing Date” has the meaning given to such term in the Reorganization Agreement.  

 

5        “NM Members” shall mean (i) New Mountain Partners V, L.P. and its Affiliates in respect  of their investment in Remedy Acquisition, LP, (ii) New Mountain Partners V (AIV-C), L.P., and  (iii) New Mountain Partners V (AIV-C2), L.P., and their respective Affiliates, in each case, other  than Pubco and its direct or indirect subsidiaries.    “Person” means any individual, corporation, partnership, limited liability company, trust,  estate, joint venture, governmental authority or other entity.    “Terminated” or “Terminates” means, with respect to Executive, a Termination of  Employment or Service, as applicable.    “Termination of Employment or Service” means a termination of employment or service  (for reasons other than a military or personal leave of absence granted by Cure TopCo) of  Executive from the Company Group. Notwithstanding the foregoing, if no rights of Executive are  reduced or adversely affected, the Compensation Committee may otherwise define Termination of  Employment or Service thereafter, provided that any such change to the definition of the term  “Termination of Employment or Service” does not subject the applicable Incentive LLC Units to  Section 409A of the Code.    2. 83(b) Elections. After the issuance of the Corresponding Incentive Units and the  Incentive LLC Units as contemplated by this Agreement, Aggregator shall execute and deliver to  the Internal Revenue Service (the “IRS”) an election under Section 83(b) of the Code with respect  to the Corresponding Incentive Units and Executive shall execute and deliver to the IRS an election  under Section 83(b) of the Code in the form attached hereto as Appendix A with respect to the  Incentive LLC Units (together the “83(b) Elections”). Executive understands that under Section  83(b) of the Code, regulations promulgated thereunder, and certain IRS administrative  announcements, in the absence of an effective election under Section 83(b) of the Code, the excess  of the fair market value of any Incentive LLC Units, on the date on which any forfeiture restrictions  applicable to such Incentive LLC Units lapse, over the price paid for such Incentive LLC Units,  could be reportable as ordinary income at that time. For this purpose, the term “forfeiture  restrictions” includes the restrictions on transferability and the vesting and reversion conditions  imposed under Sections 3 and 4 of this Agreement. Executive understands that (i) in making an  83(b) Election, Executive may be taxed at the time the Incentive LLC Units are received hereunder  to the extent the fair market value of the Incentive LLC Units exceeds the price for such Incentive  LLC Units and (ii) in order to be effective, the 83(b) Elections must be filed with the IRS within  thirty (30) days after February 12, 2021. Executive hereby acknowledges that: (x) the foregoing  description of the tax consequences of the 83(b) Elections is not intended to be complete and,  among other things, does not describe state, local or foreign income and other tax consequences;  (y) none of Cure TopCo, Aggregator, the NM Members, any of their respective Affiliates or any  of their respective partners, members, equityholders, directors, officers, employees, agents or  representatives (each, a “Related Person”) has provided or is providing Executive with tax advice  regarding the 83(b) Elections or any other matter, and Cure TopCo, Aggregator and the NM  Members and their respective Affiliates have urged Executive to consult Executive’s own tax  advisor with respect to income taxation consequences of receiving, holding and disposing of the  

 

6      Incentive LLC Units; and (z) none of Cure TopCo, Aggregator, the NM Members or any other  Related Person has advised Executive to rely on any determination by it or its representatives as  to the fair market value specified in the 83(b) Elections and will have no liability to Executive if  the actual fair market value of the Incentive LLC Units on the date hereof exceeds the amount  specified in the respective 83(b) Elections.    3. Incentive Units. The Units of Aggregator issued to Executive in exchange for  Executive’s Incentive Units (the “Incentive LLC Units”) and the LLC Units of Cure TopCo issued  to Aggregator in exchange for the Corresponding Common Units (the “Corresponding Incentive  Units”) are subject to the vesting conditions set forth in this Section 3. A portion of the Incentive  LLC Units and Corresponding Incentive Units, as set forth on Appendix B, shall be subject to  time-based vesting conditions (the “Time-Based Units”) and a portion of the Incentive LLC Units  and Corresponding Incentive Units, as set forth on Appendix B, shall be subject to performance-  based vesting conditions (the “Performance-Based Units”). For purposes of this Agreement and  the Aggregator LLC Agreement, the Incentive LLC Units and Corresponding Incentive Units  which have become vested in accordance with this Section 3 shall be referred to herein as the  “Vested Units” and the remaining Incentive LLC Units and Corresponding Incentive Units shall  be referred to herein as the “Unvested Units.” The Incentive LLC Units are subject to the  restrictions set forth in this Agreement.    3.1. Time-Based Units. Executive’s Time-Based Units shall continue to time  vest in accordance with the vesting schedule set forth on Appendix B. Except as otherwise  provided in this Agreement, there shall be no proportionate or partial vesting in the periods prior  to each vesting date set forth on Appendix B and all vesting shall occur only on the applicable  vesting date set forth on Appendix B, provided that Executive has not been Terminated prior to  each applicable vesting date. Notwithstanding the foregoing, any Time-Based Units shall become  fully vested upon the occurrence of an Acceleration Event, so long as Executive has not been  Terminated prior to the date of such Acceleration Event.    3.2. Performance-Based Units. Executive’s Performance-Based Units shall vest  based on the level of aggregate Cash-on-Cash Returns achieved by the NM Members (and/or,  without duplication, their direct and indirect parent entities) in accordance with the vesting  schedule set forth on Appendix B; provided that Executive has not been Terminated prior to the  date the applicable Cash-on-Cash Return is achieved. There shall be no proportionate or partial  vesting for levels of achievement of Cash-on-Cash Return between the performance thresholds set  forth above, and all vesting shall occur on a cliff basis only to the extent that an applicable Cash-  on-Cash Return threshold is achieved; provided that Executive has not been Terminated prior to  the date the applicable Cash-on-Cash Return is achieved. For the avoidance of doubt, in the event  that the applicable Cash-on-Cash Return is not achieved at any point in time, then the Performance-  Based Units shall remain outstanding and eligible to continue to performance vest upon a later  achievement of the applicable Cash-on-Cash Returns; provided that Executive has not been  Terminated prior to the date on which vesting occurs; and provided, further, that any Performance-  Based Units that remain unvested at such time as the NM Members or their respective direct or  indirect parent entities cease to control any Equity Securities of Pubco shall be forfeited and  cancelled.  

 

7        3.3. Call Rights. Except as otherwise provided in this Agreement, in the event  of Executive’s Termination for any reason, Aggregator may repurchase from Executive and/or, as  applicable, any of his or her Permitted Transferees the portion of the Incentive LLC Units that are  Vested Units based on the most recent valuation under Section 409A of the Code obtained by Cure  TopCo, subject to the sole discretion of the Board. For purposes of this Section 3.3, all  requirements of Executive shall apply equally in full force and effect with respect to any Permitted  Transferee.    3.3.1. Aggregator shall have a period of one hundred eighty (180) days (or  such longer period as may be necessary to avoid changing the accounting treatment for the  acquisition of the Incentive LLC Units being repurchased from an equity-based accounting  treatment to a liability based accounting treatment (as contemplated by FASB ASC Topic  718)); provided that such period shall not exceed three hundred sixty-five (365) days  following the date of Executive’s Termination, in which to give notice in writing to  Executive of Aggregator’s election to exercise its repurchase rights hereunder and thirty  (30) days after delivery of such notice to pay the repurchase price and consummate the  repurchase transaction. For the sake of clarity, Aggregator may elect to repurchase any of  the Incentive LLC Units of Executive and/or, as applicable, any of his or her Permitted  Transferees in one or more separate transactions. The repurchase price, if any, payable  pursuant to Aggregator’s exercise of its repurchase rights hereunder shall be paid (i) by  delivery to Executive of wire transfer or a certified bank check or checks in the appropriate  amount payable to the order of Executive; (ii) by the cancellation of any indebtedness owed  by Executive to Aggregator, Cure TopCo or any of their Affiliates; or (iii) by issuance of  an unsecured promissory note bearing interest (payable at maturity) at a simple rate per  annum equal to the prime rate in effect at such time, with such note to have a maturity date  of no greater than seven (7) years following its issuance and otherwise on customary terms  and conditions for promissory notes of such type, including acceleration in the event of an  Acceleration Event; or (iv) any combination of clauses (i), (ii) or (iii) of this Section 3.3.1,  as determined in the sole discretion of Aggregator. Aggregator may choose to have a  designee purchase any Incentive LLC Units elected by it to be purchased hereunder so long  as Aggregator shall bear any reasonable costs and expenses of Executive in connection  with the sale to such designee that Executive would not have otherwise incurred in  connection with a sale to Aggregator. All references to Aggregator in this Section 3.3 shall  refer to such designee as the context requires. Executive agrees to take all necessary and  reasonable actions as directed by Aggregator in connection with the consummation of a  repurchase pursuant to this Section 3.3, including executing the applicable repurchase  documentation. Without limiting the generality of the foregoing, Aggregator shall be  entitled to receive customary representations and warranties from Executive regarding the  Incentive LLC Units being repurchased including, but not limited to, the representation  that Executive has good and marketable title to the Incentive LLC Units to be repurchased  free and clear of all liens, claims and other encumbrances.    3.4. Termination of Employment. If Executive’s employment or service  relationship Terminates (other than in the case of a Termination for Cause), irrespective of whether  

 

8      Executive receives, in connection with such Termination, any severance or other payment from  Cure TopCo or any of its Affiliates under any employment or service agreement or otherwise, the  Incentive LLC Units, other than such portion that are Vested Units, shall terminate and be of no  further force and effect as of and following the close of business on the date of such Termination.  Notwithstanding anything in this Agreement to the contrary, and in addition to the rights of  Aggregator set forth in this Section 3.4 (or any other right Aggregator may have), the Incentive  LLC Units, including the portion that are Vested Units, shall immediately be forfeited and  cancelled, without any consideration being paid therefore and without further action by Aggregator  or any other Person, upon a Termination of Executive by Cure TopCo or any of its Affiliates for  Cause.    4. Restrictions on Unvested Units; Forfeiture.    4.1. Executive may not offer or Transfer or agree to offer or Transfer, grant any  call option with respect to, borrow against, or enter into any swap or derivative transaction with  respect to any Incentive LLC Unit or any interest therein, unless such action is taken in accordance  with Article VI of the Aggregator LLC Agreement. Any attempted or purported Transfer or other  agreement in violation of this Agreement will be void ab initio.    4.2. Notwithstanding anything to the contrary in the Aggregator LLC  Agreement, Executive shall not have the right to exercise (and agrees not to exercise or purport to  exercise) the “Member Exchange” under the Aggregator LLC Agreement with respect to any  Unvested Units.    4.3. If any Vested Units are purchased pursuant to the call right described in  Section 3.3, then each Corresponding Class B Share shall simultaneously be forfeited to Pubco for  no consideration in accordance with Article 4 of the Cure TopCo LLC Agreement. If any Unvested  Units or Vested Units are forfeited upon Executive’s Termination of Employment or Service under   Section 3, then each such Unvested Unit (and its Corresponding Class B Share) or Vested Unit  (and its Corresponding Class B Share), as applicable, shall be immediately and automatically  forfeited to Aggregator or Cure TopCo, as applicable (or, in the case of a Corresponding Class B  Share, to Pubco), in each case free and clear of any liens, encumbrances or restrictions,  concurrently with the Termination of Employment or Service, and shall no longer be deemed  outstanding, without the payment of consideration or notice from Aggregator, Cure TopCo or  Pubco and without the need for further action on the part of any Person.    4.4. Except as provided in this Agreement, from and after the IPO Closing Date,  Executive shall have all the rights of a member of Aggregator with respect to the Incentive LLC  Units and as a stockholder of Pubco with respect to the Corresponding Class B Shares, including  the right to vote the Corresponding Class B Share in respect of a Vested Unit; provided, that any  capital stock or securities of Aggregator or Pubco that Executive receives with respect to the  Incentive LLC Units or Corresponding Class B Shares through a stock dividend, stock split,  reverse stock split, recapitalization, or similar transaction will be subject to the same restrictions  applicable to the Incentive LLC Units or Corresponding Class B Shares with respect to which such  capital stock or other securities was distributed or received, as set forth in this Agreement.  

 

9      Executive will be the record owner of each Incentive LLC Unit until or unless such Incentive LLC  Unit reverts to Aggregator as provided under this Agreement or is Transferred in accordance with  the terms of this Agreement and the Aggregator LLC Agreement, and as record owner will be  entitled to all rights granted to owners of the LLC Units of Aggregator, except as expressly  provided under this Agreement or the Aggregator LLC Agreement.    4.5. The Corresponding Incentive Units and Incentive LLC Units shall be  uncertificated unless otherwise determined by Cure TopCo, in the case of the Corresponding  Incentive Units, or Aggregator, in the case of the Incentive LLC Units.    4.6. If Executive is not already a party to the Aggregator LLC Agreement, then  Executive agrees that upon execution of this Agreement, Executive agrees to join and become a  party to the Aggregator LLC Agreement and be fully bound by, and subject to all of the covenants,  terms and conditions of the Aggregator LLC Agreement as though an original party thereto and  Aggregator agrees to accept Executive as a party to the Aggregator LLC Agreement and that this  Agreement shall serve as Executive’s joinder to the Aggregator LLC Agreement.    4.7. By virtue of the issuance of the Incentive LLC Units hereunder and  Executive’s execution of this Agreement, Executive shall be deemed to have granted a power of  attorney to the Board of Directors of Aggregator with respect to all Incentive LLC Units owned  by Executive and acquired by Executive hereunder, which power of attorney shall, for the  avoidance of doubt, include a grant by Executive of a perpetual and irrevocable power of attorney  to Aggregator, with full right, power and authority to take all actions necessary and/or desirable  on behalf of Executive to effectuate the provisions of this Section 4.    5. Compensation Committee Discretion. The Compensation Committee shall in good  faith make all determinations necessary or appropriate to determine whether the Incentive LLC  Units shall have become vested. The Compensation Committee’s determinations shall be final,  binding and conclusive upon all parties, absent manifest error or bad faith. The Compensation  Committee may, in its sole discretion, provide for accelerated vesting of any portion of the  Incentive LLC Units at any time and for any reason.    6. No Right to Continued Service. Executive agrees that no provision contained in this  Agreement shall entitle Executive to remain employed by the Company Group, affect the right of  the Company Group to Terminate Executive’s employment at any time, or confer on Executive  any right to employment for a fixed term.    7. Executive Representations. Executive shall be deemed to acknowledge and make  the following representations and warranties and as otherwise may be requested by Cure TopCo  or Aggregator for compliance with applicable laws, and any issuances of Incentive LLC Units by  Aggregator and any issuance of Corresponding Incentive Units by Cure TopCo hereunder shall be  made in reliance upon the express representations and warranties of Executive:    7.1. Executive is acquiring and will hold the Incentive LLC Units to be issued  hereunder for investment for Executive’s account only and not with a view to, or for resale in  

 

10      connection with, any “distribution” thereof within the meaning of the Securities Act or other  applicable securities laws.    7.2. Executive will not Transfer the Incentive LLC Units in violation of this  Agreement, the Aggregator LLC Agreement, the Securities Act (or the rules and regulations  promulgated thereunder) or under any other applicable securities laws; provided that, the foregoing  shall in no way limit Executive’s ability to Transfer the Incentive LLC Units pursuant to the  provisions of the Aggregator LLC Agreement. Executive agrees that Executive will not Transfer  the Incentive LLC Units to be issued hereunder unless and until Executive has complied with all  requirements of this Agreement and the Aggregator LLC Agreement applicable to the disposition  of such Incentive LLC Units.    7.3. Executive has had the opportunity to ask questions and receive answers  from Cure TopCo and Aggregator concerning the terms and conditions of the issuance of the  Incentive LLC Units and to obtain any additional information which Cure TopCo or Aggregator  possesses or can acquire without unreasonable effort or expense that Executive has requested.    7.4. Executive is an experienced and sophisticated investor and has such  knowledge and experience in financial and business matters as are necessary to evaluate the merits  and risks of an investment in the Incentive LLC Units and the Corresponding Incentive Units.    7.5. Executive has only relied on the advice of, or has consulted with,  Executive’s own legal, financial and tax advisors, and the determination of Executive to acquire  Incentive LLC Units pursuant to this Agreement has been made by Executive independent of any  statements or opinions as to the advisability of such acquisition or as to the properties, business,  prospects or condition (financial or otherwise) of Cure TopCo, Aggregator or any of their  respective Subsidiaries which may have been made or given by any other Person (including all  Persons acquiring Incentive LLC Units on the date hereof) or by any agent or employee of such  Person and independent of the fact that any other Person has decided to become a holder of  Incentive LLC Units.    7.6. Executive hereby represents and warrants that Executive is an “accredited  investor” as defined in Rule 501(a)(6) of Regulation D of the Securities Act as the result of having  (i) individual income in excess of $200,000 in each of 2019 and 2020, or joint income with  Executive’s spouse in excess of $300,000 in each of 2019 and 2020, and (ii) a reasonable  expectation of having individual income in excess of $200,000 in 2021, or joint income with  Executive’s spouse in excess of $300,000 in 2021.    8. Specific Performance. Each of the parties agrees that any breach of the terms of  this Agreement will result in irreparable injury and damage to the other parties, for which there is  no adequate remedy at law. Each of the parties therefore agrees that in the event of a breach or  any threat of breach, the other parties shall be entitled to an immediate injunction and restraining  order to prevent such breach, threatened breach or continued breach, and/or compelling specific  performance of this Agreement, without having to prove the inadequacy of money damages as a  remedy or balancing the equities between the parties.  Such remedies shall be in addition to any  

 

11      other remedies (including monetary damages) to which the other parties may be entitled at law or  in equity. Each party hereby waives any requirement for the securing or posting of any bond in  connection with any such equitable remedy.    9. Amendments and Waivers. The Board shall have the right to amend this  Agreement with the consent of Executive; provided, however, that to the extent necessary under  any applicable law, regulation, or exchange requirement, no amendment shall be effective unless  approved by the members of Aggregator if required by applicable law, regulation, or exchange  requirement.    10. Governing Law; Venue; Service of Process; Waiver of Jury Trials.    10.1. This Agreement shall be governed by, and construed in accordance with,  the laws of the State of Delaware, without giving effect to any choice of law or conflict of law  rules or provisions (whether of the State of Delaware or any other jurisdiction) that would cause  the application of the laws of any jurisdiction other than the State of Delaware. Any dispute  relating hereto shall be heard in the state or federal courts of Delaware, and the parties agree to  jurisdiction and venue therein (it being understood and agreed that any order from any such court  may be enforced in any other jurisdiction). Each of the parties hereto hereby waives, to the fullest  extent permitted by law, any right to trial by jury of any claim, demand, action, or cause of action  arising under or related to this Agreement whether now existing or hereafter arising, and whether  in contract, tort, equity, or otherwise. The parties hereto each hereby agrees and consents that any  such claim, demand, action, or cause of action shall be decided by court trial without a jury and  that the parties hereto may file an original counterpart of a copy of this Agreement with any court  as written evidence of the consent of the parties hereto to the waiver of their right to trial by jury.    10.2. Executive (i) agrees that service of process in any such claim, demand,  action, proceeding or cause of action arising under this Agreement may be effected by mailing a  copy of such process by registered or certified mail (or any substantially similar form of mail),  postage prepaid, to such party, in the case of Executive, at Executive’s address shown in the books  and records of Aggregator or Cure TopCo, in the case of Aggregator, at Aggregator’s principal  offices, attention General Counsel, or in the case of Cure TopCo, at Cure TopCo’s principal  offices, attention General Counsel, and (ii) agrees that nothing in this Agreement shall affect the  right to effect service of process in any other manner permitted by the laws of the State of  Delaware.    11. Severability. Whenever possible, each provision of this Agreement shall be  interpreted in such manner as to be effective and valid under applicable law, but if any provision  of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable  law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any  other provision or any other jurisdiction, but this Agreement shall be reformed, construed and  enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been  contained herein.  

 

12      12. Notice. Unless otherwise provided herein, all notices, requests, demands, claims  and other communications to be given or delivered under or by reason of the provisions of this  Agreement shall be in writing and shall be deemed to have been duly received (a) upon receipt by  hand delivery, (b) upon receipt after being mailed by certified or registered mail, postage prepaid,  (c) the next business day after being sent via a nationally recognized overnight courier, or (d) upon  confirmation of delivery if transmitted by electronic mail electronic mail in portable document  format (PDF format) with an electronic read receipt requested, to the email address indicated  (provided a copy thereof is also sent by one of the other methods described in this Section 12. Such  notices, demands and other communications shall be sent to the address, email address or facsimile  number indicated below:  (a) If to Aggregator or Cure TopCo:  Cure Aggregator, LLC  Cure TopCo, LLC  c/o New Mountain Capital, L.L.C.  787 Seventh Avenue  New York, NY 10019  Attention: Vignesh Aier and Kyle Peterson  E-mail: vaier@newmountaincapital.com  kpeterson@newmountaincapital.com    Cure TopCo, LLC  4055 Valley View Lane, Suite 400  Dallas, Texas 75244  Attention: Bradford Kyle Armbrester and Steven Senneff  Email: karmbrester@signifyhealth.com  ssenneff@signifyhealth.com    with a copy (with shall not constitute notice) to:    David Polk & Wardwell, LLP  450 Lexington Avenue  New York, NY 10017  Attention: Shane Tintle and Jeffrey P. Crandall  Email: shane.tintle@davispolk.com  jeffrey.crandall@davispolk.com    (b) If to Executive, at the most recent address or electronic mail address contained in  the Aggregator’s and Cure TopCo’s records.    13. Dispute Resolution. Any dispute or disagreement which may arise under, or as a  result of, or which may in any way relate to, the interpretation, or construction or of this Agreement  shall be determined by the Compensation Committee, in good faith, whose determination shall be  final, binding and conclusive for all purposes.  

 

13        14. Successors and Assigns. This Agreement shall be binding on, inure to the benefit  of and be enforceable by Cure TopCo, Aggregator, Executive and their respective personal  representatives, heirs, successors and assigns (including all subsequent holders of one or more of  the Incentive LLC Units). Any Person acquiring or claiming an interest in an Incentive LLC Unit,  in any manner whatsoever, shall be subject to and bound by all terms, conditions and restrictions  of this Agreement without regard to whether such Person has executed a counterpart hereof or any  other document contemplated hereby.    15. Notice. All notices, consents, waivers and other communications required or  permitted by this Agreement shall be in writing and shall be deemed given to a party when  delivered or sent in accordance with Section 9.5 of the Aggregator LLC Agreement (to, in the case  of Executive, the address kept on file in Cure TopCo’s or Aggregator’s records).    16. Counterparts. This Agreement may be executed in one or more counterparts, each  of which shall be deemed to be an original but all of which together will constitute one and the  same instrument. A facsimile or portable document format (PDF) copy of a counterpart signature  page to this Agreement shall be deemed an original for all purposes.    17. Entire Agreement. This Agreement sets forth the entire agreement of the parties  hereto with respect to the subject matter contained herein and supersede all prior agreements,  promises, covenants, arrangements, communications, representations or warranties, whether oral  or written, by any officer, member, manager or representative of any party hereto in respect of  such subject matter. Without limiting the forgoing, this Agreement supersedes and replaces the  Incentive Unit Agreement (other than with respect to any restrictive covenants set forth therein)  which shall be of no further force and effect as of the IPO Closing Date.    18. Transfer of Personal Data. Executive authorizes, agrees and unambiguously  consents to the transmission by Cure TopCo or Aggregator (or any Affiliate of Cure TopCo or  Aggregator) of any personal data information related to the Incentive LLC Units awarded under  this Agreement for legitimate business purposes. This authorization and consent is freely given by  Executive.    19. Effectiveness. This Agreement shall be effective as of the IPO Closing Date  (contingent on the closing of the IPO). If the IPO Closing Date does not occur for any reason, then  (a) this Agreement shall be null and void, and (b) Executive shall continue to own the Incentive  Units subject to the Third Amended and Restated Aggregator LLC Agreement, the Second  Amended and Restated LLC Agreement and the Incentive Unit Agreement.    Signature Page Follows  

 

    SIGNATURE PAGE  TO  INCENTIVE UNIT AGREEMENT    IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the  date first above written.      Print Name: Steve Senneff          CURE TOPCO, LLC      Name:   Bradford Kyle Armbrester    Title:    Chief Executive Officer        CURE AGGREGATOR, LLC      Name:   Bradford Kyle Armbrester    Title:    Chief Executive Officer    

 

    Appendix A    PROTECTIVE ELECTION TO INCLUDE AMOUNT IN GROSS INCOME  PURSUANT TO SECTION 83(b) OF THE INTERNAL REVENUE CODE    On February 12, 2021, the undersigned acquired 506,975 LLC Units (the “Incentive LLC  Units”) of Cure Aggregator, LLC, a Delaware limited liability company (“Aggregator”) with a  value of $24.00 per Incentive LLC Unit in exchange for LLC Units of Aggregator. The total  amount paid by the undersigned for the Incentive LLC Units was LLC Units of Aggregator with  an aggregate value of $12,167,400. The Incentive LLC Units are subject to a substantial risk of  forfeiture (described below) that may not be avoided by a transfer of the Incentive LLC Units to  another person and are also subject to certain restrictions on transfer.  The undersigned desires to make an election to have the receipt of the Incentive LLC Units  taxed under the provisions of Code §83(b) at the time the undersigned acquired the Incentive LLC  Units.  Therefore, pursuant to Code §83(b) and Treasury Regulation §1.83-2 promulgated  thereunder, the undersigned hereby makes an election, with respect to the Incentive LLC Units  (described below), to report as taxable income for calendar year 2021 the excess (if any) of the  Incentive LLC Units’ fair market value on February 12, 2021 over the purchase price thereof.  The following information is supplied in accordance with Treasury Regulation §1.83-2(e):  1. The name, address and social security number of the undersigned:  Name: Steve Senneff  Address:      SSN:       2. A description of the property with respect to which the election is being made: 506,975 LLC  Units of Aggregator.  3. The date on which the Incentive LLC Units were transferred: February 12, 2021.  The taxable  year for which such election is made: 2021.  4. The restrictions to which the property is subject: Under certain circumstances, the Incentive  LLC Units may be forfeited.  5. The fair market value on February 12, 2021 of the property with respect to which the election  is being made, determined without regard to any lapse restrictions: $12,167,400.  6. The amount paid or to be paid for such property: LLC Units of Aggregator with an aggregate  fair market value of $12,167,400.  * * * * *  

 

    A copy of this election has been furnished to Aggregator pursuant to Treasury Regulations §1.83-  2(d).    Dated: , 2021          Steve Senneff  

 

    Appendix B    Number of Incentive LLC Units: 506,975  Number of Corresponding Incentive Units: 506,975    Number of Time-Based Units: 253,487  Number of Performance-Based Units: 253,488      Time-Based Unit Vesting Schedule:    25% on February 18, 2020  25% on February 18, 2021  25% on February 18, 2022  25% on February 18, 2023  Performance-Based Unit Vesting Schedule:  Percentage Vesting Cash-on-Cash Return  0.00% Less than 1.75 times the Base Equity Value  100.00% 1.75 times or more the Base Equity Value  

 

          Certificate Of Completion    Envelope Id: BDAB71F4D0D841009788329F5F49942F Status: Completed  Subject: Please DocuSign: Converted_IU_Agreement_Steven_Senneff.pdf  Source Envelope:  Document Pages: 17 Signatures: 2 Envelope Originator:  Certificate Pages: 1 Initials: 0 Barbara Waters  AutoNav: Enabled  EnvelopeId Stamping: Disabled  Time Zone: (UTC-06:00) Central Time (US & Canada)  4055 Valley View Ln # 700  Dallas, TX  75244-5074  bwaters@signifyhealth.com  IP Address: 75.115.162.90  Record Tracking    Status: Original  3/23/2021 10:08:23 AM  Holder: Barbara Waters  bwaters@signifyhealth.com  Location: DocuSign      Kyle Armbrester  karmbrester@signifyhealth.com  CEO  Security Level: Email, Account Authentication  (Optional) Signature Adoption: Pre-selected Style  Using IP Address: 68.161.208.252  Sent: 3/23/2021 10:09:51 AM  Viewed: 3/23/2021 10:19:05 AM  Signed: 3/23/2021 10:19:11 AM    Electronic Record and Signature Disclosure:  Not Offered via DocuSign                          Barbara Waters  bwaters@signifyhealth.com  Security Level: Email, Account Authentication  (Optional)  Electronic Record and Signature Disclosure:  Not Offered via DocuSign  Sent: 3/23/2021 10:09:51 AM  Resent: 3/23/2021 10:19:12 AM    Witness Events Signature Timestamp  Notary Events Signature Timestamp  Envelope Summary Events Status Timestamps  Envelope Sent  Certified Delivered  Signing Complete  Completed  Hashed/Encrypted  Security Checked  Security Checked  Security Checked  3/23/2021 10:09:51 AM  3/23/2021 10:19:05 AM  3/23/2021 10:19:11 AM  3/23/2021 10:19:11 AM  Payment Events Status Timestamps    Carbon Copy Events Status Timestamp  Certified Delivery Events Status Timestamp  Intermediary Delivery Events Status Timestamp  Agent Delivery Events Status Timestamp  Editor Delivery Events Status Timestamp  In Person Signer Events Signature Timestamp  Signer Events Signature Timestamp

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}]]